Back

DEA-HF: The heart failure diuresis efficacy comparison study

11 May 2024 (14:21 - 14:29)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials: medical therapy Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Aharon Abbo

Rambam Health Care Campus, Haifa (Israel)

9 More presentations in this session

Presentation thumbnail
A phase 2b, randomised, double-blind, active controlled, multi centre study to evaluate the efficacy, safety and tolerability of oral AZD9977 and dapagliflozin treatment in patients with heart failure
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Discussant review - MIRACLE
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
A phase 2, randomized, double-blind, placebo-controlled study to assess the tolerability and pharmacodynamic effects of CRD-740, a PDE9 inhibitor, in participants with chronic heart failure
Professor J. Udelson (Boston, US)
Slides Video
Presentation thumbnail
Discussant review - CARDINAL HF
Associate Professor A. Bohm (Bratislava, SK)
Slides Video
Presentation thumbnail
Readily available urinary sodium analysis in patients with acute decompensate Heart Failure
Doctor E. Meekers (Genk, BE)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials: medical therapy
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 14:21 CET
You may be interested in
thumbnail
Congress Presentation
Diuresis efficacy in ambulatory congested heart failure patients: Intra -patient comparison of three diuretic regimens (DEA-HF)
thumbnail
Congress Session
Late breaking clinical trials: medical therapy
thumbnail
Congress Presentation
Discussant review - DEA-HF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources